echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > In 2021, 10 patents for the original drug will expire, involving Pfizer, Roche and AbbVie! In 2021, 10 patents for the original drug will expire, involving Pfizer, Roche and AbbVie!

    In 2021, 10 patents for the original drug will expire, involving Pfizer, Roche and AbbVie! In 2021, 10 patents for the original drug will expire, involving Pfizer, Roche and AbbVie!

    • Last Update: 2021-03-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    E,2021,10,,,。 ,10,3,,V.
    .
    .

    E,2021,10,,,。 ,10,3,,V.
    .
    .

    05px;font-size:16px;text-align:center;">

    com" style="margin:0px;padding:0px;color:#333333;">

    25px;font-size:15px;margin-top:20px ;'>E,2021,10,,,。


    25px;font-size:15px;margin-top:20px ;'>,10,3,,Vascepa。



    5px;background:#3B5CF4;">“”


    25px;font-size:15px;margin-top:20px ;'>,,、,,。


    25px;font-size:15px;margin-top:20px ;'>,,。25px;font-size:15px;caret-color:red;margin-top:20px ;'>,,。,。


    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.


    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.


    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.




    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.


    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.



    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs


    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.


    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.


    25px;font-size:15px;'>Chia Tai Sunny:


    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".


    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.


    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.


    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.


    25px;font-size:15px;'>East Sunshine:


    25px;font-size:15px;margin-top:20px ;'>Dongyang Sunshine has always been committed to being the leader of the first generic drugs in domestic new drugs.


    In the first three quarters of 2020, Dongyang Sunshine was the first company with the second largest number of approved generic drugs (after China Biopharmaceuticals), and won a total of 4 first generic drug approvals.


    25px;font-size:15px;'>Hengrui:


    25px;font-size:15px;margin-top:20px ;'>As the "big brother" of local pharmaceutical companies, Hengrui has very strong R&D capabilities and strong funding.


    Therefore, it is natural not to give up the market of first generic drugs.
    In recent years, Hengrui has been focusing on high-end generic drugs and innovative drugs, and has achieved fruitful results in the first generic drug market.


    25px;font-size:15px;margin-top:20px ;'>Recently, Suhengrui Pharmaceutical Co.


    , Ltd.
    issued an announcement stating that it had recently received a "drug registration certificate" for tolvaptan tablets approved and issued by the State Drug Administration.
    Except for Hengrui Pharmaceuticals, only Zhejiang Otsuka Pharmaceutical's products have been approved for listing in China.



    25px;font-size:15px;margin-top:20px ;'>In addition, Hausen, Kelun, Qilu, etc.


    also shine in the field of first generic drugs.


    05px;font-size:16px;text-align:center;">

    com" style="margin:0px;padding:0px;color:#333333;">

    25px;font-size:15px;margin-top:20px ;'>According to the E drug manager, in 2021, 10 drugs in the U.


    S.



    25px;font-size:15px;margin-top:20px ;'>At present, three of these 10 drugs have entered China, among which ranibizumab and sunitinib have been launched, and Vascepa also landed in the Hainan Boao Lecheng Pioneer District at the beginning of this year.





    5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities


    25px;font-size:15px;margin-top:20px ;'>As we all know, although innovative drugs enjoy price advantages over generic drugs, an innovative drug usually takes much longer than generic drugs from R&D, approval to mass production, and the investment in R&D costs is also much higher.




    25px;font-size:15px;margin-top:20px ;'>If it succeeds, it’s okay.
    Once it fails, it will have a huge impact on the company.
    25px;font-size:15px;caret-color:red;margin-top:20px ;'>Especially in recent years, a large number of pharmaceutical companies have poured into the innovative drug track, and the competition is fierce.
    For small and medium-sized pharmaceutical companies or pharmaceutical companies with insufficient financial strength, the deployment of innovative drugs is not necessarily a wise decision.


    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.
    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.


    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.


    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.
    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.



    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs


    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.
    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.


    25px;font-size:15px;'>Chia Tai Sunny:


    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".
    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.


    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.
    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.


    25px;font-size:15px;'>East Sunshine:


    25px;font-size:15px;margin-top:20px ;'>Dongyang Sunshine has always been committed to being the leader of the first generic drugs in domestic new drugs.
    In the first three quarters of 2020, Dongyang Sunshine was the first company with the second largest number of approved generic drugs (after China Biopharmaceuticals), and won a total of 4 first generic drug approvals.


    25px;font-size:15px;'>Hengrui:


    25px;font-size:15px;margin-top:20px ;'>As the "big brother" of local pharmaceutical companies, Hengrui has very strong R&D capabilities and strong funding.
    Therefore, it is natural not to give up the market of first generic drugs.
    In recent years, Hengrui has been focusing on high-end generic drugs and innovative drugs, and has achieved fruitful results in the first generic drug market.


    25px;font-size:15px;margin-top:20px ;'>Recently, Suhengrui Pharmaceutical Co.
    , Ltd.
    issued an announcement stating that it had recently received a "drug registration certificate" for tolvaptan tablets approved and issued by the State Drug Administration.
    Except for Hengrui Pharmaceuticals, only Zhejiang Otsuka Pharmaceutical's products have been approved for listing in China.
    Therefore, Hengrui will become the first pharmaceutical company to be approved for the first imitation of tolvaptan tablets.


    25px;font-size:15px;margin-top:20px ;'>In addition, Hausen, Kelun, Qilu, etc.
    also shine in the field of first generic drugs.
    If medical professionals are interested in this field, they can pay more attention to these pharmaceutical companies so as to get the latest news about the first generic drugs in a timely manner.

    05px;font-size:16px;text-align:center;">


    com" style="margin:0px;padding:0px;color:#333333;">

    25px;font-size:15px;margin-top:20px ;'>According to the E drug manager, in 2021, 10 drugs in the U.
    S.
    market will lose patent protection.
    At the same time, their respective potential generic drugs will also be listed to seize their market share.


    25px;font-size:15px;margin-top:20px ;'>At present, three of these 10 drugs have entered China, among which ranibizumab and sunitinib have been launched, and Vascepa also landed in the Hainan Boao Lecheng Pioneer District at the beginning of this year.



    5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities


    25px;font-size:15px;margin-top:20px ;'>As we all know, although innovative drugs enjoy price advantages over generic drugs, an innovative drug usually takes much longer than generic drugs from R&D, approval to mass production, and the investment in R&D costs is also much higher.


    25px;font-size:15px;margin-top:20px ;'>If it succeeds, it’s okay.
    Once it fails, it will have a huge impact on the company.
    25px;font-size:15px;caret-color:red;margin-top:20px ;'>Especially in recent years, a large number of pharmaceutical companies have poured into the innovative drug track, and the competition is fierce.
    For small and medium-sized pharmaceutical companies or pharmaceutical companies with insufficient financial strength, the deployment of innovative drugs is not necessarily a wise decision.


    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.
    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.


    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.


    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.
    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.



    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs


    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.
    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.


    25px;font-size:15px;'>Chia Tai Sunny:


    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".
    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.


    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.
    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.


    25px;font-size:15px;'>East Sunshine:


    25px;font-size:15px;margin-top:20px ;'>Dongyang Sunshine has always been committed to being the leader of the first generic drugs in domestic new drugs.
    In the first three quarters of 2020, Dongyang Sunshine was the first company with the second largest number of approved generic drugs (after China Biopharmaceuticals), and won a total of 4 first generic drug approvals.


    25px;font-size:15px;'>Hengrui:


    25px;font-size:15px;margin-top:20px ;'>As the "big brother" of local pharmaceutical companies, Hengrui has very strong R&D capabilities and strong funding.
    Therefore, it is natural not to give up the market of first generic drugs.
    In recent years, Hengrui has been focusing on high-end generic drugs and innovative drugs, and has achieved fruitful results in the first generic drug market.


    25px;font-size:15px;margin-top:20px ;'>Recently, Suhengrui Pharmaceutical Co.
    , Ltd.
    issued an announcement stating that it had recently received a "drug registration certificate" for tolvaptan tablets approved and issued by the State Drug Administration.
    Except for Hengrui Pharmaceuticals, only Zhejiang Otsuka Pharmaceutical's products have been approved for listing in China.
    Therefore, Hengrui will become the first pharmaceutical company to be approved for the first imitation of tolvaptan tablets.


    25px;font-size:15px;margin-top:20px ;'>In addition, Hausen, Kelun, Qilu, etc.
    also shine in the field of first generic drugs.
    If medical professionals are interested in this field, they can pay more attention to these pharmaceutical companies so as to get the latest news about the first generic drugs in a timely manner.

    25px;font-size:15px;margin-top:20px ;'>According to the E drug manager, in 2021, 10 drugs in the U.
    S.
    market will lose patent protection.
    At the same time, their respective potential generic drugs will also be listed to seize their market share.

    25px;font-size:15px;margin-top:20px ;'>According to the E drug manager, in 2021, 10 drugs in the U.
    S.
    market will lose patent protection.
    At the same time, their respective potential generic drugs will also be listed to seize their market share.


    25px;font-size:15px;margin-top:20px ;'>At present, three of these 10 drugs have entered China, among which ranibizumab and sunitinib have been launched, and Vascepa also landed in the Hainan Boao Lecheng Pioneer District at the beginning of this year.



    25px;font-size:15px;margin-top:20px ;'>At present, three of these 10 drugs have entered China, among which ranibizumab and sunitinib have been launched, and Vascepa also landed in the Hainan Boao Lecheng Pioneer District at the beginning of this year.

    25px;font-size:15px;margin-top:20px ;'>At present, three of these 10 drugs have entered China, among which ranibizumab and sunitinib have been launched, and Vascepa also landed in the Hainan Boao Lecheng Pioneer District at the beginning of this year.



    5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities


    25px;font-size:15px;margin-top:20px ;'>As we all know, although innovative drugs enjoy price advantages over generic drugs, an innovative drug usually takes much longer than generic drugs from R&D, approval to mass production, and the investment in R&D costs is also much higher.


    25px;font-size:15px;margin-top:20px ;'>If it succeeds, it’s okay.
    Once it fails, it will have a huge impact on the company.
    25px;font-size:15px;caret-color:red;margin-top:20px ;'>Especially in recent years, a large number of pharmaceutical companies have poured into the innovative drug track, and the competition is fierce.
    For small and medium-sized pharmaceutical companies or pharmaceutical companies with insufficient financial strength, the deployment of innovative drugs is not necessarily a wise decision.


    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.
    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.


    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.


    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.
    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.



    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs


    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.
    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.


    25px;font-size:15px;'>Chia Tai Sunny:


    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".
    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.


    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.
    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.


    25px;font-size:15px;'>East Sunshine:


    25px;font-size:15px;margin-top:20px ;'>Dongyang Sunshine has always been committed to being the leader of the first generic drugs in domestic new drugs.
    In the first three quarters of 2020, Dongyang Sunshine was the first company with the second largest number of approved generic drugs (after China Biopharmaceuticals), and won a total of 4 first generic drug approvals.


    25px;font-size:15px;'>Hengrui:


    25px;font-size:15px;margin-top:20px ;'>As the "big brother" of local pharmaceutical companies, Hengrui has very strong R&D capabilities and strong funding.
    Therefore, it is natural not to give up the market of first generic drugs.
    In recent years, Hengrui has been focusing on high-end generic drugs and innovative drugs, and has achieved fruitful results in the first generic drug market.


    25px;font-size:15px;margin-top:20px ;'>Recently, Suhengrui Pharmaceutical Co.
    , Ltd.
    issued an announcement stating that it had recently received a "drug registration certificate" for tolvaptan tablets approved and issued by the State Drug Administration.
    Except for Hengrui Pharmaceuticals, only Zhejiang Otsuka Pharmaceutical's products have been approved for listing in China.
    Therefore, Hengrui will become the first pharmaceutical company to be approved for the first imitation of tolvaptan tablets.


    25px;font-size:15px;margin-top:20px ;'>In addition, Hausen, Kelun, Qilu, etc.
    also shine in the field of first generic drugs.
    If medical professionals are interested in this field, they can pay more attention to these pharmaceutical companies so as to get the latest news about the first generic drugs in a timely manner.


    5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities
    5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunities5px;background:#3B5CF4;">Generic drugs usher in "cliff" opportunitiesGeneric drugs usher in "cliff" opportunities



    25px;font-size:15px;margin-top:20px ;'>As we all know, although innovative drugs enjoy price advantages over generic drugs, an innovative drug usually takes much longer than generic drugs from R&D, approval to mass production, and the investment in R&D costs is also much higher.

    25px;font-size:15px;margin-top:20px ;'>As we all know, although innovative drugs enjoy price advantages over generic drugs, an innovative drug usually takes much longer than generic drugs from R&D, approval to mass production, and the investment in R&D costs is also much higher.



    25px;font-size:15px;margin-top:20px ;'>If it succeeds, it’s okay.
    Once it fails, it will have a huge impact on the company.
    25px;font-size:15px;caret-color:red;margin-top:20px ;'>Especially in recent years, a large number of pharmaceutical companies have poured into the innovative drug track, and the competition is fierce.
    For small and medium-sized pharmaceutical companies or pharmaceutical companies with insufficient financial strength, the deployment of innovative drugs is not necessarily a wise decision.

    25px;font-size:15px;margin-top:20px ;'>If it succeeds, it’s okay.
    Once it fails, it will have a huge impact on the company.
    25px;font-size:15px;caret-color:red;margin-top:20px ;'>Especially in recent years, a large number of pharmaceutical companies have poured into the innovative drug track, and the competition is fierce.
    For small and medium-sized pharmaceutical companies or pharmaceutical companies with insufficient financial strength, the deployment of innovative drugs is not necessarily a wise decision.



    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.
    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.

    25px;font-size:15px;margin-top:20px ;'>As a result, some pharmaceutical companies began to focus on the field of first generic drugs.
    25px;caret-color:red;font-size:15px;margin-top:20px ;'>It should be known that once the patent of the original research drug expires, as the first generic drug, it is 25px;font-size:15px;margin-top:20px ;'>expected to quickly replace the expensive original research product with a low price, and it has an advantage over subsequent follow-ups in terms of pricing policy.



    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.

    25px;caret-color:red;font-size:15px;'>Therefore, for the generic drug market, the first imitation means the market, and the first imitation and patent breaking will become the new normal for the domestic drug market.



    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.
    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.

    25px;font-size:15px;caret-color:#FF0000;'>With the expiration of many blockbuster patents around the world, generic drug companies are about to usher in a "cliff" opportunity.
    Therefore, whether it is a pharmaceutical company or a medical person, it may be a good opportunity to try to turn its attention to the first generic drug.


    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs
    5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugs5px;background:#3B5CF4;">The first leading pharmaceutical company in the field of generic drugsThe first leading pharmaceutical company in the field of generic drugs



    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.
    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.

    25px;font-size:15px;margin-top:20px ;'>Compared with ordinary generic drugs, the first generic drugs require stronger R&D technology.
    Therefore, among the domestic local pharmaceutical companies, several leading pharmaceutical companies have been "conscientiously" in the first generic drug market, becoming the leader in the domestic first generic drug market.



    25px;font-size:15px;'>Chia Tai Sunny:

    25px;font-size:15px;'>Chia Tai Sunny:25px;font-size:15px;'> Chia Tai Sunny:25px;font-size:15px;'> Chia Tai Sunny:



    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".
    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.

    25px;font-size:15px;margin-top:20px ;'>Since 2008, CP Tianqing has been focusing on making the first copy, and is known as the "king of the first copy".
    Last year (2020), Chia Tai Tianqing had 16 varieties for the first imitation.



    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.
    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.

    25px;font-size:15px;margin-top:20px ;'>Recently, Chia Tai Tianqing’s application for the 4 generic drug "lenvatinib mesylate capsules" (acceptance number: CYHS1900381) has been changed to "under approval" status.
    Chia Tai Tianqing may become the first company to be approved for lenvatinib.
    Nissan is a pharmaceutical company with imitation varieties.



    25px;font-size:15px;'>East Sunshine:

    25px;font-size:15px;'>East Sunshine:25px;font-size:15px;'> East Sunshine:25px;font-size:15px;'> East Sunshine:



    25px;font-size:15px;margin-top:20px ;'>,。20203,(),4。

    25px;font-size:15px;margin-top:20px ;'>,。20203,(),4。



    25px;font-size:15px;'>:

    25px;font-size:15px;'>:25px;font-size:15px;'>:25px;font-size:15px;'>:



    25px;font-size:15px;margin-top:20px ;'>“”,,。,。,,。

    25px;font-size:15px;margin-top:20px ;'>“”,,。,。,,。



    25px;font-size:15px;margin-top:20px ;'>,,《》。,。,。

    25px;font-size:15px;margin-top:20px ;'>,,《》。,。,。



    25px;font-size:15px;margin-top:20px ;'>,、、,。,,。

    25px;font-size:15px;margin-top:20px ;'>,、、,。,,。
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.